158 related articles for article (PubMed ID: 24574100)
1. The syntheses, characterization and in vitro metabolism of nitracaine, methoxypiperamide and mephtetramine.
Power JD; Scott KR; Gardner EA; Curran McAteer BM; O'Brien JE; Brehon M; Talbot B; Kavanagh PV
Drug Test Anal; 2014; 6(7-8):668-75. PubMed ID: 24574100
[TBL] [Abstract][Full Text] [Related]
2. Identification of in vitro and in vivo human metabolites of the new psychoactive substance nitracaine by liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
Negreira N; Kinyua J; De Brabanter N; Maudens K; van Nuijs AL
Anal Bioanal Chem; 2016 Jul; 408(19):5221-9. PubMed ID: 27185541
[TBL] [Abstract][Full Text] [Related]
3. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
Meyer MR; Holderbaum A; Kavanagh P; Maurer HH
J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
[TBL] [Abstract][Full Text] [Related]
4. Metabolism study and toxicological determination of mephtetramine in biological samples by liquid chromatography coupled with high-resolution mass spectrometry.
Odoardi S; Mestria S; Biosa G; Arfè R; Tirri M; Marti M; Strano Rossi S
Drug Test Anal; 2021 Aug; 13(8):1516-1526. PubMed ID: 33835674
[TBL] [Abstract][Full Text] [Related]
5. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
Grafinger KE; Hädener M; König S; Weinmann W
Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
[TBL] [Abstract][Full Text] [Related]
6. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
Franz F; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
[TBL] [Abstract][Full Text] [Related]
7. Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues.
Wallach J; De Paoli G; Adejare A; Brandt SD
Drug Test Anal; 2014; 6(7-8):633-50. PubMed ID: 23554350
[TBL] [Abstract][Full Text] [Related]
8. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864).
Moosmann B; Bisel P; Westphal F; Wilde M; Kempf J; Angerer V; Auwärter V
Drug Test Anal; 2019 Mar; 11(3):541-549. PubMed ID: 30578721
[TBL] [Abstract][Full Text] [Related]
9. Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-α-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, α-PiHP, 4-Cl-α-PHP, and 4-F-α-PHP.
Liu C; Jia W; Li T; Hua Z; Qian Z
Drug Test Anal; 2017 Aug; 9(8):1162-1171. PubMed ID: 27863142
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
[TBL] [Abstract][Full Text] [Related]
11. The synthesis and characterization of the 'research chemical' N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer.
McLaughlin G; Morris N; Kavanagh PV; Power JD; Twamley B; O'Brien J; Talbot B; Dowling G; Brandt SD
Drug Test Anal; 2016 Sep; 8(9):920-9. PubMed ID: 26360802
[TBL] [Abstract][Full Text] [Related]
12. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.
Moosmann B; Bisel P; Franz F; Huppertz LM; Auwärter V
J Mass Spectrom; 2016 Nov; 51(11):1080-1089. PubMed ID: 27535017
[TBL] [Abstract][Full Text] [Related]
13. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
[TBL] [Abstract][Full Text] [Related]
14. Identification and analytical characterization of four synthetic cannabinoids ADB-BICA, NNL-1, NNL-2, and PPA(N)-2201.
Qian Z; Jia W; Li T; Hua Z; Liu C
Drug Test Anal; 2017 Jan; 9(1):51-60. PubMed ID: 27239006
[TBL] [Abstract][Full Text] [Related]
15. Keeping pace with NPS releases: fast GC-MS screening of legal high products.
Elie MP; Elie LE; Baron MG
Drug Test Anal; 2013 May; 5(5):281-90. PubMed ID: 23297247
[TBL] [Abstract][Full Text] [Related]
16. An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials.
Strano Rossi S; Odoardi S; Gregori A; Peluso G; Ripani L; Ortar G; Serpelloni G; Romolo FS
Rapid Commun Mass Spectrom; 2014 Sep; 28(17):1904-16. PubMed ID: 25088134
[TBL] [Abstract][Full Text] [Related]
17. An investigation of the stability of emerging new psychoactive substances.
Soh YN; Elliott S
Drug Test Anal; 2014; 6(7-8):696-704. PubMed ID: 24573920
[TBL] [Abstract][Full Text] [Related]
18. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
Sobolevsky T; Prasolov I; Rodchenkov G
Drug Test Anal; 2012 Oct; 4(10):745-53. PubMed ID: 23042760
[TBL] [Abstract][Full Text] [Related]
19. Identification of three cannabimimetic indazole and pyrazole derivatives, APINACA 2H-indazole analogue, AMPPPCA, and 5F-AMPPPCA.
Jia W; Meng X; Qian Z; Hua Z; Li T; Liu C
Drug Test Anal; 2017 Feb; 9(2):248-255. PubMed ID: 26968728
[TBL] [Abstract][Full Text] [Related]
20. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
